Why INMB? INmune Bio Inc. Analysis, Price & AI Insights | Whystock
INMB
$1.50-0.00 (-0.33%)
Market OpenUpdated 10:23 AM EDT
INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.